These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 3285833)

  • 1. Comparative study on the antihypertensive efficacy of torasemide and indapamide in patients with essential hypertension.
    Spannbrucker N; Achhammer I; Metz P; Glocke M
    Arzneimittelforschung; 1988 Jan; 38(1A):190-3. PubMed ID: 3285833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of efficacy and tolerance of different oral doses of torasemide and furosemide in patients with advanced chronic renal failure.
    Kult J; Häcker W; Glocke M
    Arzneimittelforschung; 1988 Jan; 38(1A):212-4. PubMed ID: 3285837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter dose-response study of the effect of indapamide in the treatment of patients with mild to moderate hypertension.
    Capone P; Vukovich RA; Neiss ES; Bolton S; Reeves RL
    Clin Ther; 1983; 5(3):305-16. PubMed ID: 6342786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacodynamics of torasemide and furosemide in patients with oedema.
    Herchuelz A; Deger F; Douchamps J; Ducarne H; Broekhuysen J
    Arzneimittelforschung; 1988 Jan; 38(1A):180-3. PubMed ID: 3285831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy and safety of indapamide in essential hypertension.
    Morledge JH
    Am Heart J; 1983 Jul; 106(1 Pt 2):229-32. PubMed ID: 6346846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formal comparison of the antihypertensive effects of torasemide and other diuretics by the Montevideo mathematical model.
    Reyes AJ
    Arzneimittelforschung; 1988 Jan; 38(1A):194-9. PubMed ID: 3370066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Torasemide, a new potent diuretic. Double-blind comparison with furosemide.
    Broekhuysen J; Deger F; Douchamps J; Ducarne H; Herchuelz A
    Eur J Clin Pharmacol; 1986; 31 Suppl():29-34. PubMed ID: 3536530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of intracellular sodium and calcium in essential hypertension during diuretic treatment.
    Spieker C; Zidek W; Häcker W; Schmidt W; Vetter H
    Arzneimittelforschung; 1988 Jan; 38(1A):188-90. PubMed ID: 3370065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of indapamide in the treatment of hypertension.
    Anavekar SN; Ludbrooke A; Louis WJ; Doyle AE
    J Cardiovasc Pharmacol; 1979; 1(4):389-94. PubMed ID: 94616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind comparison of indapamide with a placebo in hypertensive patients treated by practicing physicians.
    Schaller MD; Waeber B; Brunner HR
    Clin Exp Hypertens A; 1985; 7(7):985-94. PubMed ID: 3899418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion from 2.5 mg to 1.25 mg indapamide in patients with mild to moderate hypertension.
    Levine B; Lee W; Boyd G; Chrysant S; Dawson J; Gardner T; Hill G; Vergis J; Codispoti J; Stokes A
    J Fam Pract; 1995 Jul; 41(1):75-80. PubMed ID: 7798068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of torasemide in patients with chronic heart failure.
    Achhammer I; Häcker W; Glocke M
    Arzneimittelforschung; 1988 Jan; 38(1A):184-7. PubMed ID: 3285832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent salidiuretic efficacy of torasemide in comparison to furosemide and placebo in advanced renal failure.
    Mourad G; Haecker W; Mion C
    Arzneimittelforschung; 1988 Jan; 38(1A):205-8. PubMed ID: 3285835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indapamide versus beta-blocker therapy: a double-blind, crossover study in essential hypertension.
    Rumboldt Z; Rumboldt M; Jurisic M
    Curr Med Res Opin; 1984; 9(1):10-20. PubMed ID: 6373155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of additional administration of low-dose indapamide on patients with hypertension treated with angiotensin II receptor blocker.
    Yamada H; Mishiro Y; Kusunose K; Sata M
    J Cardiovasc Pharmacol Ther; 2010 Jun; 15(2):145-50. PubMed ID: 20200326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of muzolimine and indapamide during treatment for essential hypertension.
    Kirsten R; Molz KH; Tzonev I; Nelson K
    Z Kardiol; 1985; 74 Suppl 2():66-72. PubMed ID: 4002807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic benefit of a low dose of indapamide: results of a double-blind against placebo European controlled study].
    Asmar R; Guez D; Malbezin M; Brault Y; de Cordoue A; Barrandon S; Bruxelles MC; Chastang C
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1083-7. PubMed ID: 8572850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effects of torasemide prolonged release in mild-to-moderate hypertension: a randomized noninferiority trial versus torasemide immediate release.
    Roca-Cusachs A; Aracil-Vilar J; Calvo-Gómez C; Vaquer-Pérez JV; Laporta-Crespo F; Rojas-Serrano MJ; Guglietta A; Gropper S;
    Cardiovasc Ther; 2008; 26(2):91-100. PubMed ID: 18485132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single dose comparison of torasemide and furosemide in patients with advanced renal failure.
    Klütsch K; Grosswendt J; Haecker W
    Arzneimittelforschung; 1988 Jan; 38(1A):200-4. PubMed ID: 3285834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group.
    Ambrosioni E; Safar M; Degaute JP; Malin PL; MacMahon M; Pujol DR; de Cordoüe A; Guez D
    J Hypertens; 1998 Nov; 16(11):1677-84. PubMed ID: 9856369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.